Oncology Gaps in breast cancer care in Europe and the importance of g... Breast cancer places a pressing burden on patients, physicians, and healthcare systems.
R&D Early detection of cancers will require blood sweat and tear... An NHS study of a new cancer blood test holds huge promise, but will not be without its challenges, says Snedden Campbell’s Ivor Campbell.
News NHS England starts largest ever trial of Galleri cancer bloo... A blood test called Galleri that could detect dozens of different forms of cancer before symptoms appear will start trials by the NHS in England involving around 140,000 subjects.<
Views & Analysis Bowel cancer: improving rates of diagnosis Impact of bowel cancer home test on diagnosis.
Views & Analysis Digital health round-up: Apple ventures into the Land of Nod Apple becomes first 'big tech' firm to investigate sleep technology.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
